An overview of molecular abnormalities leading to thyroid carcinogenesis: A 1993 perspective

Stem Cells

Volumn 15, Issue SUPPL. 2, 1997, Pages 7-13

  Gagel, Robert F ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Medullary thyroid carcinoma; Mutation; Oncogene; Papillary follicular thyroid carcinoma

Indexed keywords

PROTEIN P53; RAS PROTEIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

CARCINOGENESIS; CHROMOSOME 10; CONFERENCE PAPER; GENE MUTATION; GENE REARRANGEMENT; ONCOGENE RAS; RADIATION EXPOSURE; SIPPLE SYNDROME; THYROID CARCINOMA; THYROID MEDULLARY CARCINOMA;

EID: 0030665833     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.5530150705     Document Type: Conference Paper

References (22)

1. Kazakov VS, Demidchik EP, Astakhova LN. Thyroid cancer after Chemobyl. Nature 1992;359:21.
2. Baverstock K, Egloff B, Pinchera A et al. Thyroid cancer after Chemobyl. Nature 1992;359:21-22.
3. Simpson NE, Kidd KK, Goodfellow PJ et al. Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage. Nature 1987;328:528-530.
4. Mathew CG, Chin KS, Easton DF et al. A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10. Nature 1987;328:527-528.
5. Wynford-Thomas D. Molecular basis of epithelial tumorigenesis: the thyroid model. Clin Rev Oncogenesis 1993;4:1-23.
6. '6 Lyons J, Landis CA, Harsh G et al. Two G protein oncogeneses in human endocrine tumors. Science 1990;249:655-659.
7. Santoro M, Rosati R, Grieco M et al. The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas. Oncogene 1990;5:1595-1598.
8. Lanzi C, Borrello MG, Bongarzone I et al. Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas. Oncogene 1992;7:2189-2194.
9. Takahashi M, Buma Y, Iwamoto T et al. Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains. Oncogene 1988;3:571-578.
10. Takahashi M. Structure and expression of the ret transforming gene. IARC Sci Publ 1988;92:189-197.
11. Fagin JA, Matsuo K, Karmakar A et al. High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. J Clin Invest 1993;91:179-184.
12. Mulligan LM, Kwok JBJ, Healey CS et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A (MEN 2A). Nature 1993;363:458-460.
13. Donis-Keller H, Dou S, Chi D et al. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 1993;2:851-856.
14. Takahashi M, Ritz J, Cooper GM. Activation of a novel human transforming gene, ret, by DNA rearrangement. Cell 1985;42:581-588.
15. Xing S, Smanik PA, Oglesbee MJ et al. Characterization of ret oncogenic activation in MEN 2 inherited cancer syndromes. Endocrinology 1996;137:1512-1519.
16. Asai N, Iwashita T, Matsuyama M et al. Mechanisms of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations. Mol Cell Biol 1995;15:1613-1619.
17. Santoro M, Carlomagno F, Romano A et al. Activation of RET as a dominant transforming gene by germline mutations of MEN 2A and MEN 2B. Science 1995;267:381-383.
18. Jing S, Wen D, Yu Y et al. GDNF-induced activation of the Ret protein tyrosine kinase is mediated by GDMFR-a, a novel receptor for GDNF. Cell 1996;85:1113-1124.
19. Durbec P, Marcos-Gutierrez CV, Kilkenny C et al. GDNF signalling through the ret receptor tyrosine kinase. Nature 1996;381:789-793.
20. Trupp M, Arenas E, Falnzilber M et al. Functional receptor for GDNF encoded by the c-ret protooncogene. Nature 1996;381:785-788.
21. Bongarzone I, Butti MG, Coronelli S et al. Frequent activation of RET protooncogene by fusion with a new activating gene in papillary thyroid carcinomas. Cancer Res 1994;54:2979-2985.
22. Jhiang SM, Sagartz JE, Tong Q et al. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology 1996;137:375-378.